Gynecologic Cancer News

A dramatic rise in global incidence of early-onset cancers over the past 30 years may be related in part to increased exposure to risk factors at a young age, according to study results published in Nature Reviews Clinical Oncology,

Overall cancer mortality among American Indian/Alaska Native individuals appeared higher than among white individuals despite similar cancer incidence, according to findings published in CA: A Cancer Journal for Clinicians.

During their lifetime, one in 70 women will receive a diagnosis of ovarian cancer, which is the second most common gynecologic cancer in the United States, according to Memorial Sloan Kettering Cancer Center.

Scientists from Denmark and the United States have engineered a yeast commonly used in foods to produce the precursor molecules for the anticancer agent vinblastine, a drug that has been in shortage several times in recent years.

A greater number of live births causally reduced the risk for endometrial cancer, according to study results published in BMC Medicine.

The FDA granted accelerated approval to mirvetuximab soravtansine-gynx for treatment of certain adults with epithelial ovarian, fallopian tube or primary peritoneal cancer.

A novel monocyte-derived cell therapy showed evidence of migrating from the blood to the tumor microenvironment for several solid tumor types, according to phase 1 study results.

Treatment of advanced, recurrent and metastatic cervical cancer has come a long way in the past 15 years, and data on novel combinations and therapies provide hope for further progress, a speaker at Chemotherapy Foundation Symposium said.

Black women in the U.S. appeared less likely than white women to receive guideline-concordant treatment for ovarian cancer, according to a study published in Journal of the National Comprehensive Cancer Network.

Cancer death rates declined broadly between 2015 and 2019 in the United States as overall incidence remained generally stable, according to the Annual Report to the Nation on the Status of Cancer.